CHAR T-cells: Transplant immunology to (re)enter the field of personalised medicine?

Lloyd J D'Orsogna^{1

2}, Rhonda Holdsworth³

Affiliations

¹ School of Medicine, University of Western Australia, Nedlands, Western Australia, Australia.
² Department of Clinical Immunology and PathWest, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
³ Australian Red Cross LifeBlood, Melbourne, Victoria, Australia.

Editorial

Lloyd J D'Orsogna et al. HLA. 2023 Oct.

. 2023 Oct;102(4):433-435.

doi: 10.1111/tan.15199.

Lloyd J D'Orsogna^{1

2}, Rhonda Holdsworth³

¹ School of Medicine, University of Western Australia, Nedlands, Western Australia, Australia.
² Department of Clinical Immunology and PathWest, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
³ Australian Red Cross LifeBlood, Melbourne, Victoria, Australia.

No abstract available

References

1. Dausset J. Iso-leuko-antibodies. Acta Haematol. 1958;20(1-4):156-166. doi:10.1159/000205478
1. Van Rood JJ, Eernisse JG, Van Leeuwen A. Leucocyte antibodies in sera from pregnant women. Nature. 1958;181(4625):1735-1736. doi:10.1038/1811735a0
1. Cheigh JS, Chami J, Stenzel KH, et al. Renal transplantation between HLA identical siblings. Comparison with transplants from HLA semi-identical related donors. N Engl J Med. 1977;296(18):1030-1034. doi:10.1056/NEJM197705052961803
1. Cappell KM, Kochenderfer JN. Long-term outcomes following CAR T cell therapy: what we know so far. Nat Rev Clin Oncol. 2023;20(6):359-371. doi:10.1038/s41571-023-00754-1
1. Schinstock C, Tambur A, Stegall M. Current approaches to desensitization in solid organ transplantation. Front Immunol. 2021;12:686271. doi:10.3389/fimmu.2021.686271